LICENSE AGREEMENT between UroGen Pharma, Ltd. and Allergan Pharmaceuticals International Limited Dated as of October 7, 2016License Agreement • April 7th, 2017 • UroGen Pharma Ltd. • Pharmaceutical preparations
Contract Type FiledApril 7th, 2017 Company IndustryThis License Agreement (this “Agreement”) is made and entered into as of October 7, 2016 (the “Effective Date”) by and between UroGen Pharma Ltd., a corporation organized under the laws of Israel (“UroGen”) and Allergan Pharmaceuticals International Limited, a corporation organized under the laws of Ireland (“Allergan”). UroGen and Allergan are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT between UroGen Pharma, Ltd. and Allergan Pharmaceuticals International Limited Dated as of October 7, 2016License Agreement • December 28th, 2016 • UroGen Pharma Ltd. • Pharmaceutical preparations
Contract Type FiledDecember 28th, 2016 Company IndustryThis License Agreement (this “Agreement”) is made and entered into as of October 7, 2016 (the “Effective Date”) by and between UroGen Pharma Ltd., a corporation organized under the laws of Israel (“UroGen”) and Allergan Pharmaceuticals International Limited, a corporation organized under the laws of Ireland (“Allergan”). UroGen and Allergan are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”